Trial Profile
Cladribine alone and in combination with cyclophosphamide or cyclophosphamide plus mitoxantrone in the treatment of progressive chronic lymphocytic leukemia.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs Cladribine (Primary) ; Cyclophosphamide (Primary) ; Mitoxantrone (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.